IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA
© 2024 BioAdvance. All Rights Reserved. | Privacy Policy | Site by Loudmark
101 West Elm Street, Suite 330, Conshohocken, PA 19428 | (610) 230-0544
IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA
© 2024 BioAdvance. All Rights Reserved. | Privacy Policy | Site by Loudmark
101 West Elm Street, Suite 330, Conshohocken, PA 19428 | (610) 230-0544